TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Bioform AS
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
14,101
|
8,373
|
10,934 |
Financial expenses |
91
|
93
|
25 |
Earnings before taxes |
5,745
|
536
|
3,104 |
Total assets |
13,694
|
11,642
|
10,542 |
Current assets |
11,347
|
9,975
|
9,328 |
Current liabilities |
1,365
|
3,463
|
2,462 |
Equity capital |
12,329
|
8,180
|
8,080 |
- share capital |
464
|
495
|
522 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
90.0%
|
70.3%
|
76.6% |
Turnover per employee | |||
Profit as a percentage of turnover |
40.7%
|
6.4%
|
28.4% |
Return on assets (ROA) |
42.6%
|
5.4%
|
29.7% |
Current ratio |
831.3%
|
288.0%
|
378.9% |
Return on equity (ROE) |
46.6%
|
6.6%
|
38.4% |
Change turnover |
6,243
|
-1,987
|
5,364 |
Change turnover % |
79%
|
-19%
|
96% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.